Article Details

A look at SUDA Pharmaceuticals' Product Portfolio

Retrieved on: 2019-05-28 13:04:50

Tags for this article:

Click the tags to see associated articles and topics

A look at SUDA Pharmaceuticals' Product Portfolio. View article details on hiswai:

Excerpt

<div>SUDA granted a license to Teva for the distribution and marketing of ... to $9.5 in 2017, according to <b>Arcview Market Research</b> and BDS Analytics.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up